Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preclinical and clinical evidence for suppression of alcohol intake by apremilast
Kolter B. Grigsby, Regina A. Mangieri, Amanda J. Roberts, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Blood metabolomic profiling reveals new targets in the management of psychological symptoms associated with severe alcohol use disorder
Sophie Leclercq, Hany Ahmed, Camille Amadieu, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
Neuroimmune modulators as novel pharmacotherapies for substance use disorders
Erica N. Grodin
Brain Behavior & Immunity - Health (2024) Vol. 36, pp. 100744-100744
Open Access | Times Cited: 1
Blood metabolomic profiling reveals new targets in the management of psychological symptoms associated with alcohol use disorder
Sophie Leclercq, Hany Ahmed, Camille Amadieu, et al.
(2024)
Open Access | Times Cited: 1
The Predictive Value of Plasma Bioactive Lipids on Craving in Human Volunteers With Alcohol Use Disorder
Cristina Miliano, Luis A. Natividad, Susan Quello, et al.
Biological Psychiatry Global Open Science (2024) Vol. 4, Iss. 6, pp. 100368-100368
Open Access | Times Cited: 1
Contribution of Visceral Systems to the Development of Substance Use Disorders: Translational Aspects of Interaction between Central and Peripheral Mechanisms
Д. И. Перегуд, N. V. Gulyaeva
Biochemistry (Moscow) (2024) Vol. 89, Iss. 11, pp. 1868-1888
Open Access | Times Cited: 1
Effects of the Phosphodiesterase 10A Inhibitor MR1916 on Alcohol Self-Administration and Striatal Gene Expression in Post-Chronic Intermittent Ethanol-Exposed Rats
Luísa Becker Bertotto, Dolly Lampson-Stixrud, Anushka Sinha, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 321-321
Open Access
Blood metabolomic profiling reveals new targets in the management of psychological symptoms associated with severe alcohol use disorder
Sophie Leclercq, Hany Ahmed, Camille Amadieu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alcohol use disorder and body mass index show genetic pleiotropy and shared neural associations
Samantha G. Malone, Christal N. Davis, Zachary Piserchia, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The PDE4 inhibitor apremilast modulates ethanol responses in Gabrb1-S409A knock-in mice via PKA-dependent and independent mechanisms
Yuri A. Blednov, William Shawlot, Gregg E. Homanics, et al.
Neuropharmacology (2024) Vol. 257, pp. 110035-110035
Closed Access
Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury
Dalton W. Staller, Robert G. Bennett, Ram I. Mahato
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 7, pp. 545-573
Closed Access
Blood metabolomic profiling reveals new targets in the management of psychological symptoms associated with severe alcohol use disorder
Sophie Leclercq, Hany Ahmed, Camille Amadieu, et al.
(2024)
Open Access
Effects of metformin on binge‐like ethanol drinking and adenosine monophosphate kinase signaling in inbred high drinking in the dark line 1 mice
Kolter B. Grigsby, Jonathan Palacios, Amy Chan, et al.
Alcohol Clinical and Experimental Research (2024) Vol. 48, Iss. 12, pp. 2269-2280
Closed Access
Blood metabolomic profiling reveals new targets in the management of psychological symptoms associated with severe alcohol use disorder
Sophie Leclercq, Hany Ahmed, Camille Amadieu, et al.
eLife (2024) Vol. 13
Open Access
Pharmacotherapies for Alcohol Use Disorder
Evguenia Makovkina
Psychiatry update (2024), pp. 77-91
Closed Access
Modern pharmacotherapy guidance for treating alcohol use disorders
Michael Soyka, Susanne Rösner
Expert Opinion on Pharmacotherapy (2024)
Closed Access
Central Amygdala Neuroimmune Signaling in Alcohol Use Disorder
Mariam Melkumyan, Patrick A. Randall, Yuval Silberman
Addiction Neuroscience (2024), pp. 100194-100194
Open Access
Alcohol drinking is attenuated by PDE4 inhibition but partial microglia depletion is not sufficient to block stress-induced escalation of alcohol intake in female mice
Vernon Garcia‐Rivas, Alexa R. Soares, Merrilee Thomas, et al.
Alcohol (2024) Vol. 122, pp. 31-42
Closed Access
Semaglutide: A Promising Treatment for Alcohol Use Disorder
Chelsi Patton, Amanda E. Brooks, Benjamin D. Brooks, et al.
(2023)
Open Access | Times Cited: 1
Pill for a skin disease also curbs excessive drinking

Nature (2023) Vol. 614, Iss. 7947, pp. 198-198
Closed Access
Modeling Brain Gene Expression in Alcohol Use Disorder with Genetic Animal Models
Robert Hitzemann, Angela R. Ozburn, Denesa R. Lockwood, et al.
Current topics in behavioral neurosciences (2023)
Closed Access
Quoi de neuf en recherche ?
Adèle de Masson
Annales de Dermatologie et de Vénéréologie - FMC (2023) Vol. 3, Iss. 8, pp. 8S22-8S29
Closed Access
Previous Page - Page 2

Scroll to top